Search

everythinglearnresearchcommunity

for

Search:↓

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Created microspheres show potential for safe and effective use in prostate artery embolization.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Finasteride increases CD8+ T cells in BPH tissues.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Blood pressure that doesn't drop at night is linked to worse blood vessel function in people with high blood pressure.

Finasteride worsens stress effects on sensory processes, possibly linking to anxiety/depression.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Drugs like PDEI may help hair disorders like AGA.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Minoxidil with propranolol and diuretics lowers blood pressure but causes fluid retention and hair growth.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Dutasteride is a safe and effective treatment for hair loss.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.